# Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients

> **NCT00958997** · — · COMPLETED · sponsor: **Yale University** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** 18F-FP-DTBZ (18F-AV-133)
- **BIOLOGICAL:** Arginine-hydrochloride

## Key facts

- **NCT ID:** NCT00958997
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-10
- **Final completion:** 2012-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00958997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00958997, "Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00958997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*